Culture & Sensitivity, Aerobic bacteria Body Fluids Specify type (Manual method)

Bacterial/ Viral

Report in 72Hrs

At Home

No Fasting Required

Details

Identify aerobic bacterial pathogens causing infections in sterile body cavities

₹299₹1,600

81% OFF

Culture & Sensitivity Aerobic bacteria Body Fluids - Comprehensive Medical Test Guide

Section 1: Why is it done?
- Test Purpose: This test identifies and isolates aerobic bacteria present in body fluids and determines their susceptibility to various antibiotics using manual culture and sensitivity methods.
- Primary Indications: Suspected bacterial infection in body fluids (cerebrospinal fluid, synovial fluid, pleural fluid, peritoneal fluid, pericardial fluid, ascitic fluid)
- Clinical Scenarios: Fever of unknown origin, signs of meningitis, septic arthritis, empyema, peritonitis, or other localized infections requiring fluid analysis
- Antibiotic Guidance: To guide targeted antimicrobial therapy by identifying specific pathogens and their antibiotic susceptibilities
- Typical Timing: Performed urgently when infection is suspected; results typically available within 24-72 hours depending on bacterial growth rate
Section 2: Normal Range
- Normal Result: No growth of aerobic bacteria after 48-72 hours of incubation (Reported as: NO GROWTH or STERILE)
- Interpretation of Negative Result: Indicates absence of aerobic bacterial infection in the specimen; excludes common bacterial pathogens but does not rule out viral, fungal, or anaerobic infections
- Abnormal Result - Positive Growth: Isolation of one or more bacterial species indicates presence of infection; reported with organism identification and colony count when applicable
- Sensitivity Report Units: Reported as SUSCEPTIBLE (S), INTERMEDIATE (I), or RESISTANT (R) to specific antibiotics; may include minimum inhibitory concentration (MIC) values in micrograms/mL
- Normal vs Abnormal Distinction: Sterile body fluids should contain NO bacteria; any bacterial growth is considered abnormal and clinically significant in cerebrospinal, synovial, pleural, peritoneal, and pericardial fluids
Section 3: Interpretation
- Positive Culture with Single Organism: Strongly suggests true infection; organism identity guides initial antibiotic selection. Common pathogens include Streptococcus pneumoniae, Neisseria meningitidis, Escherichia coli, Staphylococcus aureus, and Listeria monocytogenes depending on fluid type and patient population
- Positive Culture with Multiple Organisms: May indicate polymicrobial infection or specimen contamination; clinical correlation essential. Repeat sampling may be recommended to confirm true infection
- Susceptible (S) Result: Indicates antibiotic will likely be effective; organism's growth is inhibited at achievable drug concentrations; preferred antibiotic for treatment
- Intermediate (I) Result: Uncertain clinical efficacy; treatment depends on drug concentration achievable at infection site, dosing regimen, and clinical response; alternative antibiotics often preferred
- Resistant (R) Result: Antibiotic will not be effective; organism growth continues despite antibiotic exposure; alternative antibiotics to which organism is susceptible must be selected
- Factors Affecting Interpretation: Prior antibiotic exposure, contamination risk, specimen quality, collection method, transport conditions, time to processing, organism virulence, patient immune status, and anatomical site of infection all influence clinical significance
- Clinical Correlation Essential: Results must be interpreted with clinical presentation, patient symptoms, vital signs, imaging findings, and other laboratory values; culture results guide but do not replace clinical judgment
Section 4: Associated Organs
- Primary Organ Systems: Central nervous system (meningitis), musculoskeletal system (septic arthritis), respiratory system (empyema, pneumonia), cardiovascular system (pericarditis), gastrointestinal system (peritonitis)
- Cerebrospinal Fluid (CSF) Culture: Diagnoses meningitis; common organisms include Streptococcus pneumoniae, Neisseria meningitidis, group B Streptococcus; critical for CNS infection management
- Synovial Fluid Culture: Identifies septic arthritis; common pathogens include Staphylococcus aureus, Streptococcus species, gram-negative bacilli; essential for joint preservation and infection control
- Pleural Fluid Culture: Detects empyema; organisms reflect underlying pneumonia or systemic infection; guides treatment of respiratory complications
- Peritoneal/Ascitic Fluid Culture: Diagnoses spontaneous bacterial peritonitis (SBP) or secondary peritonitis; critical in cirrhotic patients and acute abdomen evaluation
- Pericardial Fluid Culture: Identifies bacterial pericarditis; differentiates infectious from non-infectious causes; critical for preventing tamponade and permanent cardiac damage
- Associated Diseases and Complications: Sepsis, septic shock, permanent neurological damage (meningitis sequelae), joint destruction, cardiac tamponade, organ failure, death if untreated; early identification and targeted therapy reduce morbidity and mortality
Section 5: Follow-up Tests
- Repeat Culture if Indicated: Repeat sampling after 48-72 hours of antibiotic therapy to assess treatment response; especially important for meningitis, septic arthritis, and bacteremia
- Blood Cultures: Simultaneous aerobic and anaerobic blood cultures to detect concurrent bacteremia; assists in source identification and antimicrobial therapy guidance
- Anaerobic Bacterial Culture: When anaerobic infection suspected; complements aerobic culture for comprehensive pathogen identification, particularly in peritoneal and pleural infections
- Fungal Culture: When fungal infection suspected, particularly in immunocompromised patients; uses same specimen for broader microbial evaluation
- Gram Stain and Cell Count: Microscopic examination of same specimen provides rapid preliminary information; morphology and cell counts support provisional diagnosis pending culture results
- Molecular/PCR Testing: Rapid detection of specific bacterial pathogens (particularly useful for meningitis panels); complements culture by providing faster preliminary results
- Serology/Antigen Detection: Rapid immunological tests for specific organisms (e.g., bacterial antigens in meningitis); provides preliminary information while awaiting culture
- Extended Susceptibility Testing: ESBL, carbapenemase, or other resistance mechanism testing based on resistance patterns; MRSA and VRSA detection as indicated
- Clinical Chemistry Parameters: Glucose, protein, lactate, LDH in same specimen; supports infection diagnosis and monitors therapy response
- Imaging Studies: CT, ultrasound, or MRI to identify loculated fluid, complications, or source of infection based on culture findings
- Monitoring Frequency: Repeat cultures every 24-48 hours until negative in severe infections; clinical response assessed daily; therapy adjusted based on culture results and susceptibility patterns within 24-48 hours of receipt
Section 6: Fasting Required?
- Fasting Requirement: NO - Fasting is not required for this test
- Specimen Collection Method: Body fluid obtained via sterile aspiration/drainage procedure (lumbar puncture for CSF, arthrocentesis for synovial fluid, thoracentesis for pleural fluid, paracentesis for peritoneal fluid, pericardiocentesis for pericardial fluid)
- Specimen Handling Requirements: Collect in sterile container WITHOUT preservatives or antiseptics; transport to laboratory IMMEDIATELY (within 15-30 minutes) at room temperature; do NOT refrigerate as this may kill fastidious organisms; prolonged delay reduces culture sensitivity
- Specimen Volume: Minimum 1 mL for routine culture; larger volumes (3-5 mL when possible) improve culture sensitivity for organisms in low concentration
- Pre-procedure Preparation: Patient education on procedure; positioning assistance; informed consent typically required; vitals assessment; anxiety management as needed
- Medications - No Restrictions: Routine medications may be continued unless specifically instructed otherwise; anticoagulants should be reviewed pre-procedure; antibiotics may be initiated after specimen collection without affecting culture results if collected before treatment
- Special Instructions: Inform laboratory and provider of prior antibiotics used; notify if immunocompromised; communicate fungal or atypical infection concerns for extended incubation; specify fluid type clearly on requisition (CSF, synovial, pleural, peritoneal, pericardial, other)
- Post-procedure Care: Monitor vital signs; observe for procedure complications; maintain sterile dressing; report fever, increased pain, drainage, or neurological changes immediately

How our test process works!